myvisionsouth.com
  • Home
  • About
  • Partners
    • iCare >
      • iCare Fundus Imaging
      • iCare Perimetry
      • iCare Tonometry
    • Firefly
    • Eyefficient
    • MedViaRX
    • S4 Optik
    • Micro Medical Devices
    • AcuityPro
    • PlenOptika
    • Samaritan Biologics
  • Quote Request
  • Pre-Owned Equipment
  • Contact
Picture
VisionSouth Partner
Picture
Picture
​
​
What is EyeGen?

EyeGen is a single layer, human amniotic membrane (HAM) allograft provided in several sizes and utilized by doctors in the treatment of a variety of ocular conditions.
 How are HAM’s used?Human amniotic membrane (HAM) can be applied to the surface of the eye to cover or offer protection from the surrounding environment in ocular repair and reconstruction procedures.
 Are these grafts safe?These grafts are terminally sterilized to a Sterility Assurance Level (SAL) of 10-6, and rigorously tested to meet or exceed current FDA, State, and American Association of Tissue Banks (AATB) standards to ensure safety.

How long have Ophthalmic doctors used HAM?
  • In 1940, de Roth is the first person credited with using fetal membranes in ophthalmic surgery.1
  • Sorsby and Symons first reported use for treatment of chemical burns in 1946.2
  • Over the past 25 years there have been many publications detailing the benefits of amniotic membrane for an increasing variety of ophthalmic applications.3,4

References
  1. De Roth A: Plastic repair of conjunctival defects with fetal membranes. Arch Ophthamology: 23:522-5, 1940
  2. Sorsby & Symons: Amniotic Membrane Grafts in Caustic Burns of the Eye. Br J. Ophthalmology: 30; 337-45 1946
  3. Amniotic Membrane Transplantation for Conjunctival Surface Reconstruction https://www.sciencedirect.com/science/article/pii/S0002939414716939#!
  4. The Amniotic Membrane in Ophthalmology, Harminder S. Dua, MD, FRCS, PhD1 Jose A.P. Gomes, MD, PhD2, Anthony J. King, MD, FRCS1, and V. Senthil Maharajan, MS, FRCS1


EyeGen is The Next Generation of Ocular Treatment
​
  • EyeGen Features
    • Optimized handling characteristics
    • Proprietary processing technique
    • Terminally sterilized to a Sterility Assurance Level (SAL) OF 10-6
 
  • Rigorously Tested to Meet or Exceed Current FDA Standards to Ensure Safety
 
  • Ease of Use
    • Ready to apply out of package
    • No thawing needed
    • No glue or sutures required




​For information on Samaritan Biologics and `EyeGen
contact Greg Shackelford
CONTACT VISIONSOUTH
901-461-2100
[email protected]
Home
About
Tech Support
​
Quote Request
Technology
Financing
​
Used Equipment
Contact Us
VisionSouth ©2019
Website by Judson Creative
Proudly powered by Weebly
  • Home
  • About
  • Partners
    • iCare >
      • iCare Fundus Imaging
      • iCare Perimetry
      • iCare Tonometry
    • Firefly
    • Eyefficient
    • MedViaRX
    • S4 Optik
    • Micro Medical Devices
    • AcuityPro
    • PlenOptika
    • Samaritan Biologics
  • Quote Request
  • Pre-Owned Equipment
  • Contact